Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net loss	$ (29,142)	$ (21,501)	$ (38,688)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	5,382	4,687	3,494
Operating lease right-of-use assets expense	6,270	6,234	5,945
Foreign currency remeasurement loss	866	0	835
Stock-based compensation	39,059	36,048	37,218
Deferred income taxes	498	(864)	3,701
Other	(67)	1,068	(607)
Change in value of earn-out and warrant liabilities	37,276	11,454	(4,402)
Changes in operating assets and liabilities:
Accounts receivable	(4,898)	(19,448)	(14,388)
Prepaid expenses and other current assets	(3,350)	(2,773)	(2,108)
Deferred contract costs and other assets	(8,482)	(7,687)	(9,596)
Accounts payable, accrued expenses and other current liabilities, operating lease liabilities and other liabilities	16,046	609	(2,553)
Deferred revenue	29,436	26,867	20,375
Net cash provided by (used in) operating activities	88,894	34,694	(774)
Investing activities
Maturities of investments	5,353	2,620	183,554
Purchases of investments	(1,819)	(3,497)	(180,969)
Cash paid in business combinations and asset acquisitions, net of cash acquired	0	0	(18,572)
Capitalization of internal-use software	(1,211)	(1,434)	(1,612)
Purchase of property and equipment	(3,044)	(2,087)	(3,853)
Issuance of notes receivables	(1,750)	(1,250)	0
Other investing activities	(130)	0	0
Net cash used in investing activities	(2,601)	(5,648)	(21,452)
Financing activities
Purchase of common stock	(33,053)	(39,036)	(19,927)
Proceeds from warrant exercises	17,182	0	0
Proceeds from stock option exercises	11,033	5,569	2,818
Redemption of redeemable noncontrolling interest	(6,130)	0	0
Purchase of public warrants	(3,991)	0	0
Company earn-out shares settled in cash	(572)	0	0
Repayments of finance leases	(6)	(64)	(39)
Payments of debt issuance costs	0	(136)	0
Net cash used in financing activities	(15,537)	(33,667)	(17,148)
Effect of exchange rates on cash	(3,183)	595	(1,655)
Net increase (decrease) in cash and cash equivalents	67,573	(4,026)	(41,029)
Cash and cash equivalents at beginning of period	223,162	227,188	268,217
Cash and cash equivalents at end of period	290,735	223,162	227,188
Supplemental disclosures of cash flow information
Income taxes paid	6,882	6,112	3,320
Contingent considerations in business combination	0	0	5,635
Common stock issued in business combination	0	0	1,517
Loan to certain acquiree shareholders	0	0	235
Company earn-out shares issuance	$ 53,871	$ 0	$ 0